Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radha Rajasingham
David R Boulware

Showing results (31-40 of 435) with videos related to

Pageof 44
Sort By:
Medical Mycology|March 30, 2022
Determinants of cryptococcal antigen (CrAg) screening uptake in Kampala, Uganda: An assessment of health center characteristicsDiksha Srishyla, Gabriel Saemisch, Fred Turya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2025
Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in Outpatients With Advanced HIV DiseaseTessa Adzemovic, Elizabeth Nalintya, Ann Fieberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2025
Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of careElizabeth L Schwartz, Elizabeth K Nalintya, Caleb P Skipper, et al.
BMC Infectious Diseases|March 25, 2017
Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in UgandaAnu Ramachandran, Yukari Manabe, Radha Rajasingham, et al.
Expert Review of Anti-Infective Therapy|September 29, 2025
Can liposomal amphotericin B be used as a preventive measure for cryptococcal meningitis?Elizabeth L Schwartz, Nathan C Bahr, Radha Rajasingham
Open Forum Infectious Diseases|January 30, 2020
The Effect of Infectious Diseases Consultation on Mortality in Hospitalized Patients With Methicillin-Resistant <i>Staphylococcus aureus</i>, <i>Candida</i>, and <i>Pseudomonas</i> Bloodstream InfectionsSupavit Chesdachai, Susan Kline, Derrek Helmin, et al.
Open Forum Infectious Diseases|October 27, 2018
The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected PersonsRadha Rajasingham, Nira R Pollock, Benjamin P Linas
The New England Journal of Medicine|July 16, 2020
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. ReplyElizabeth C Okafor, Katelyn A Pastick, Radha Rajasingham
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2018
Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized TrialDavid B Meya, Agnes N Kiragga, Elizabeth Nalintya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 15, 2025
Effectiveness of a national reflex laboratory cryptococcal antigen screening programme for people with advanced HIV disease in South Africa: a nationwide-sampled cohort study (CAST-NET)Nelesh P Govender, Greg S Greene, Kathy Huppler Hullsiek, et al.
Pageof 44

Showing results (31-40 of 435) with videos related to

Sort By:
Pageof 44
Medical Mycology|March 30, 2022
Determinants of cryptococcal antigen (CrAg) screening uptake in Kampala, Uganda: An assessment of health center characteristicsDiksha Srishyla, Gabriel Saemisch, Fred Turya, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 25, 2025
Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in Outpatients With Advanced HIV DiseaseTessa Adzemovic, Elizabeth Nalintya, Ann Fieberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2025
Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of careElizabeth L Schwartz, Elizabeth K Nalintya, Caleb P Skipper, et al.
BMC Infectious Diseases|March 25, 2017
Cost-effectiveness of CRAG-LFA screening for cryptococcal meningitis among people living with HIV in UgandaAnu Ramachandran, Yukari Manabe, Radha Rajasingham, et al.
Expert Review of Anti-Infective Therapy|September 29, 2025
Can liposomal amphotericin B be used as a preventive measure for cryptococcal meningitis?Elizabeth L Schwartz, Nathan C Bahr, Radha Rajasingham
Open Forum Infectious Diseases|January 30, 2020
The Effect of Infectious Diseases Consultation on Mortality in Hospitalized Patients With Methicillin-Resistant <i>Staphylococcus aureus</i>, <i>Candida</i>, and <i>Pseudomonas</i> Bloodstream InfectionsSupavit Chesdachai, Susan Kline, Derrek Helmin, et al.
Open Forum Infectious Diseases|October 27, 2018
The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected PersonsRadha Rajasingham, Nira R Pollock, Benjamin P Linas
The New England Journal of Medicine|July 16, 2020
Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. ReplyElizabeth C Okafor, Katelyn A Pastick, Radha Rajasingham
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2018
Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized TrialDavid B Meya, Agnes N Kiragga, Elizabeth Nalintya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 15, 2025
Effectiveness of a national reflex laboratory cryptococcal antigen screening programme for people with advanced HIV disease in South Africa: a nationwide-sampled cohort study (CAST-NET)Nelesh P Govender, Greg S Greene, Kathy Huppler Hullsiek, et al.
Pageof 44